A mutation that triggers cancer might sound like a death sentence. If cellular instructions are miswritten, a cell, no matter where it resides, can embark on a path towards becoming a tumor. Now, a new study sheds light on a mechanism that dictates the development of brain cancer, potentially averting such a grim fate.
The brain presents an even more peculiar narrative. The identical mutation can spark a tumor in one locale while vanishing in another, leaving neighboring cells unharmed. However, recent research has uncovered what determines the ensuing events. The findings of this investigation are published in the journal Proceedings of the National Academy of Sciences.
To trace this critical juncture, a team from the Peter MacCallum Cancer Centre utilized fruit flies (Drosophila melanogaster), a well-established substitute for humans. The laboratory was spearheaded by Professor Louise Cheng, with Khanh Nguyen undertaking the majority of the hands-on work.
The researchers deactivated a gene that typically maintains mature neurons in their stable, adult state. Without its influence, these neurons reverted to a more youthful, dividing form. Cells exhibiting this characteristic were observed throughout the fly’s brain.
Subsequent developments were contingent on the specific brain region. In certain parts of the brain, these regressed cells gave rise to tumors. In others, they either perished or transformed back into normal neurons, despite harboring the exact same genetic defect.
One molecule coincided with the site of this divergence. A protein known as Chinmo was present where tumors developed and absent where they did not. It appeared to function as a molecular switch governing this distinction.
The story unfolded across three domains. Within the central brain and the nerve cord extending down the body, the developmentally arrested cells persisted in dividing long after growth should have ceased. These cells subsequently formed tumors.
In regions responsible for processing visual information, these same cells were discreetly eliminated. Chinmo played a pivotal role. When the team experimentally introduced this molecule into the cells of the visual region, tumors began to form in areas that had previously been unaffected.
Conversely, when the Chinmo molecule was withdrawn from tumor-prone zones, the cells disappeared, even though the cancer-causing mutation remained present. This defect had set the stage, but it was this molecule that determined whether the situation would escalate into malignancy.
“We discovered that we could alter the fate of cells carrying the precise same mutation by turning Chinmo on or off,” stated Cheng.
Chinmo’s activity is not uniformly high nor does it persist indefinitely. Its levels are elevated during early developmental stages, gradually declining as the fly matures. Different regions adhere to distinct timelines of activity.
Whether a mutated cell encounters Chinmo hinges on its location and the brain’s stage of development. This temporal aspect helps explain a mystery observed in humans.
Certain brain cancers target specific areas, even when their underlying mutations appear identical. Researchers have long suspected that location concealed an unspoken pattern. No one had previously connected this to a molecule that emerges and recedes according to the brain’s developmental trajectory.
The team has coined a term for this phenomenon. They refer to Chinmo as a “competence factor”—something that enables a cell to even respond to a cancerous mutation. Without it, the mutation lies dormant, unable to be triggered.
Something must govern Chinmo’s activity. The study links this regulation to a hormone that ensures the fly’s development proceeds on schedule. In the visual processing areas, this hormone suppresses Chinmo, preventing the regressed cells from ever forming tumors.
In locations where the researchers intercepted this signal, Chinmo remained active, and the cells continued to proliferate, leading to tumor formation. The risk of developing a tumor was dictated by hormonal signaling and timing, not solely by the mutation itself.
This revelation reshapes the scientific understanding of why one altered cell becomes lethal while another experiences the same changes without consequence. While the mutation is significant, so too are the circumstances under which it arises and the opportune moment of its occurrence.
All of this transpired in fruit flies. Their utility stems from the fact that both flies and humans share the majority of genes implicated in disease development and possess similar fundamental mechanisms controlling cell growth.
About the Author
